These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2909725)

  • 21. Characterization of a gastrin-type receptor on rabbit gastric parietal cells using L365,260 and L364,718.
    Roche S; Bali JP; Galleyrand JC; Magous R
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G182-8. PubMed ID: 1996638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and SAR of new 5-phenyl-3-ureido-1,5-benzodiazepines as cholecystokinin-B receptor antagonists.
    Ursini A; Capelli AM; Carr RA; Cassarà P; Corsi M; Curcuruto O; Curotto G; Dal Cin M; Davalli S; Donati D; Feriani A; Finch H; Finizia G; Gaviraghi G; Marien M; Pentassuglia G; Polinelli S; Ratti E; Reggiani AM; Tarzia G; Tedesco G; Tranquillini ME; Trist DG; Van Amsterdam FT
    J Med Chem; 2000 Oct; 43(20):3596-613. PubMed ID: 11020274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combinatorial solid phase synthesis of multiply substituted 1,4-benzodiazepines and affinity studies on the CCK2 receptor (part 1).
    Lattmann E; Billington DC; Poyner DR; Arayarat P; Howitt SB; Lawrence S; Offel M
    Drug Des Discov; 2002; 18(1):9-21. PubMed ID: 12375632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.
    Evans BE; Bock MG; Rittle KE; DiPardo RM; Whitter WL; Veber DF; Anderson PS; Freidinger RM
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4918-22. PubMed ID: 3014519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.
    Chang RS; Lotti VJ
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4923-6. PubMed ID: 3014520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel glutamic acid derived cholecystokinin receptor ligands.
    Freidinger RM; Whitter WL; Gould NP; Holloway MK; Chang RS; Lotti VJ
    J Med Chem; 1990 Feb; 33(2):591-5. PubMed ID: 2299627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Gastrin" and "CCK" receptors on histamine- and somatostatin-containing cells from rabbit fundic mucosa-II. Characterization by means of selective antagonists (L-364,718 and L-365,260).
    Roche S; Gusdinar T; Bali JP; Magous R
    Biochem Pharmacol; 1991 Jul; 42(4):771-6. PubMed ID: 1714276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of variation in L-365,260 competition curves in radioligand binding assays.
    Harper EA; Roberts SP; Shankley NP; Black JW
    Br J Pharmacol; 1996 Aug; 118(7):1717-26. PubMed ID: 8842437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.
    Evans BE; Rittle KE; Bock MG; DiPardo RM; Freidinger RM; Whitter WL; Lundell GF; Veber DF; Anderson PS; Chang RS
    J Med Chem; 1988 Dec; 31(12):2235-46. PubMed ID: 2848124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small synthetic ligands of the cholecystokinin-B/gastrin receptor can mimic the function of endogenous peptide hormones.
    Beinborn M; Chen C; DeMeo L; McBride EW; Kopin AS
    Yale J Biol Med; 1998; 71(3-4):337-46. PubMed ID: 10461364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and structure-activity relationships of dual histamine H2 and gastrin receptor antagonists with decreased hydrophobicity.
    Kawanishi Y; Ishihara S; Tsushima T; Hagishita S; Ishikawa M; Ishihara Y
    Bioorg Med Chem; 1997 Jul; 5(7):1401-9. PubMed ID: 9377100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tifluadom, a kappa-opiate agonist, acts as a peripheral cholecystokinin receptor antagonist.
    Chang RS; Lotti VJ; Chen TB; Keegan ME
    Neurosci Lett; 1986 Dec; 72(2):211-4. PubMed ID: 3027627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists.
    Evans BE; Rittle KE; Bock MG; DiPardo RM; Freidinger RM; Whitter WL; Gould NP; Lundell GF; Homnick CF; Veber DF
    J Med Chem; 1987 Jul; 30(7):1229-39. PubMed ID: 2885419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ; Tang KW; Woodruff GN; McKnight AT
    Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted 1,4-benzodiazepin-2-amines.
    Bock MG; DiPardo RM; Evans BE; Rittle KE; Freidinger RM; Chang RS; Lotti VJ
    J Med Chem; 1988 Jan; 31(1):264-8. PubMed ID: 3336026
    [No Abstract]   [Full Text] [Related]  

  • 36. The seventh transmembrane domain of gastrin/CCK receptors contributes to non-peptide antagonist binding.
    Mantamadiotis T; Baldwin GS
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1382-9. PubMed ID: 8024583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrin13 and the C-terminal octapeptide of cholecystokinin are differently coupled to G-proteins in guinea-pig brain membranes.
    Lallement JC; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J
    Eur J Pharmacol; 1994 May; 267(3):297-305. PubMed ID: 8088368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of YM022: its CCKB/gastrin receptor binding profile and antagonism to CCK-8-induced Ca2+ mobilization.
    Saita Y; Yazawa H; Honma Y; Nishida A; Miyata K; Honda K
    Eur J Pharmacol; 1994 Oct; 269(2):249-54. PubMed ID: 7851501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase.
    Ding XQ; Chen D; Håkanson R
    Gastroenterology; 1995 Oct; 109(4):1181-7. PubMed ID: 7557084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations within the cholecystokinin-B/gastrin receptor ligand 'pocket' interconvert the functions of nonpeptide agonists and antagonists.
    Bläker M; Ren Y; Gordon MC; Hsu JE; Beinborn M; Kopin AS
    Mol Pharmacol; 1998 Nov; 54(5):857-63. PubMed ID: 9804620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.